1. Immunohistochemical staining for RXR subtypes within benign and endometrioid endometrial carcinoma.
Immunohistochemical staining for RXR subtypes within benign and endometrioid endometrial carcinoma. A, negative control for RXRα in benign endometrium. B, RXRα expression in benign endometrium. C, negative control for RXRα in G1 endometrial cancer. D, RXRα expression in G1 endometrial cancer. E, negative control for RXRβ in benign endometrium. F, RXRβ expression in benign endometrium, G, negative control for RXRβ in G3 endometrial cancer, H, RXRβ expression in G3 endometrial cancer, I, negative control for RXRγ in benign endometrium. J, RXRγ expression in benign endometrium. K, negative control for RXRγ in G1 endometrial cancer. L, RXRγ expression in G1 endometrial cancer. For each negative control, sections were incubated with nonimmune IgG instead of primary antibody. Scale bar, 100 μmol/L.
Mahshid Nickkho-Amiry et al. Mol Cancer Res 2012;10:
©2012 by American Association for Cancer Research